Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Institution | 932 624 | 8,88% | US$ 7,56M | 2026-04-27 |
| RA Capital Healthcare Fund, L.P. | Institution | 932 624 | 8,88% | US$ 7,56M | 2026-04-27 |
| OrbiMed Advisors LLC | Institution | 844 787 | 8,04% | US$ 6,85M | 2026-04-10 |
| Franklin Resources, Inc. | Institution | 626 571 | 5,97% | US$ 5,08M | 2026-03-31 |
| Caduceus Private Investments V, L.P. | Institution | 564 147 | 5,37% | US$ 4,58M | 2026-04-10 |
| Citadel Advisors LLC | Institution | 381 823 | 3,64% | US$ 3,10M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 336 524 | 3,20% | US$ 2,73M | 2026-03-31 |
| Woodline Partners LP | Institution | 313 124 | 2,98% | US$ 2,54M | 2026-03-31 |
| OrbiMed Private Investments VI, LP | Institution | 280 640 | 2,67% | US$ 2,28M | 2026-04-10 |
| Adage Capital Management, L.P. | Institution | 274 375 | 2,61% | US$ 2,23M | 2026-03-31 |
| Prosight Management, LP | Institution | 250 244 | 2,38% | US$ 2,03M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 232 591 | 2,21% | US$ 1,89M | 2026-03-31 |
| Stonepine Capital Management LLC | Institution | 221 955 | 2,11% | US$ 1,80M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 203 799 | 1,94% | US$ 1,65M | 2026-03-31 |
| Abingworth LLP | Institution | 184 295 | 1,76% | US$ 1,49M | 2026-03-31 |
| Nextbio Capital Management Lp | Institution | 157 827 | 1,50% | US$ 1,28M | 2026-03-31 |
| Acadian Asset Management LLC | Institution | 118 138 | 1,13% | US$ 958,10k | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 101 135 | 0,96% | US$ 820,20k | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 93 812 | 0,89% | US$ 760,82k | 2026-03-31 |
| Burkehill Global Management, LP | Institution | 62 500 | 0,60% | US$ 506,88k | 2026-03-31 |
| Regeneron Pharmaceuticals, Inc. | Institution | 60 511 | 0,58% | US$ 490,74k | 2026-03-31 |
| Rangeley Capital, LLC | Institution | 56 000 | 0,53% | US$ 454,16k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 53 827 | 0,51% | US$ 436,54k | 2026-03-31 |
| Dr. Aya Jakobovits | Initiés | 53 541 | 0,51% | US$ 434,22k | 2025-04-17 |
| Vanguard Fiduciary Trust Company | Institution | 50 334 | 0,48% | US$ 408,21k | 2026-03-31 |
| Trexquant Investment LP | Institution | 43 666 | 0,42% | US$ 354,13k | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 43 106 | 0,41% | US$ 349,59k | 2026-03-31 |
| RBF Capital LLC | Institution | 38 582 | 0,37% | US$ 312,90k | 2026-03-31 |
| UBS Asset Management AG | Institution | 38 368 | 0,37% | US$ 311,16k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 37 084 | 0,35% | US$ 300,75k | 2026-03-31 |
| BlackRock, Inc. | Institution | 36 585 | 0,35% | US$ 296,70k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 36 222 | 0,34% | US$ 293,76k | 2026-03-31 |
| Barclays Bank PLC | Institution | 25 000 | 0,24% | US$ 202,75k | 2026-03-31 |
| Johnson & Johnson Innovation - JJDC, Inc. | Institution | 22 779 | 0,22% | US$ 184,74k | 2026-03-31 |
| Northern Trust Global Investments | Institution | 19 200 | 0,18% | US$ 155,71k | 2026-03-31 |
| XTX Markets Limited | Institution | 19 126 | 0,18% | US$ 155,11k | 2026-03-31 |
| Occudo Quantitative Strategies LP | Institution | 15 100 | 0,14% | US$ 122,46k | 2026-03-31 |
| Vontobel Asset Management, Inc. | Institution | 14 247 | 0,14% | US$ 115,54k | 2026-03-31 |
| Mr. Chen Schor | Initiés | 11 411 | 0,11% | US$ 92,54k | 2026-01-24 |
| Dimensional Fund Advisors LP | Institution | 10 778 | 0,10% | US$ 87,41k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.